BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 9, 2026
Home
» 1999 British Biotechnology Stock Report
1999 British Biotechnology Stock Report
Jan. 1, 2000
Company Name
Symbol
12/31/98*
3/31/99
6/30/99
9/30/99
12/31/99
%YTD
British Biotech
BBG
32
16.5
22.5
33
29.5
-8
Cambridge Antibdy
CAT
229
243.5
187.5
206.5
637.5
178
Cantab Pharma
CTB
249
200.5
193
142.5
201.5
-19
Celltech Group
CTP
400
400.5
495
457.5
531.5
33
Oxford Asymmetry
OAI
522
403.5
355
355
236.5
-55
Oxford GlycoSci
OGS
261
317.5
313.5
326
515
97
Oxford Molecular
OMG
50
49.5
45.5
37.5
30
-40
Peptide Therap
PTE
172
97.5
78
40
51.5
-70
Phytopharm
PYM
83
242.5
234
267.5
435
424
PowderJect
PJP
540
910
839
740
822.5
52
PPL Therapeutics
PTH
540
112.5
103.5
82.5
83.5
-85
Scotia Holdings
SOH
79
101.5
114
167.5
133
68
Skyepharma
SKP
63
60.5
49
52.25
48.25
-23
Vanguard Medica
VGD
171
222.5
240
230
127.5
-25
Xenova
XEN
64
86.5
93.5
90
79
23
Note: * Prices denoted in pence.
Article reprints
To read more on related topics, click on one of the words below.
Medical technology
Related Articles
2000 British Biotechnology Stock Report
1999 Biotechnology Stock Report
2000 Canadian Biotechnology Stock Report